OVERVIER

Epithalon (Epitalon) is a synthetic tetrapeptide composed of the amino acid sequence alanine–glutamic acid–aspartic acid–glycine (Ala-Glu-Asp-Gly). It was developed in research on aging and pineal gland function and has been studied for its potential influence on cellular senescence and telomere biology. In laboratory experiments, Epithalon has been reported to stimulate telomerase activity in certain human somatic cell cultures, theoretically supporting telomere maintenance. Telomeres are protective DNA–protein structures at the ends of chromosomes that shorten with cell division and are associated with biological aging. Preclinical research has also explored Epithalon’s potential effects on antioxidant activity, circadian rhythm regulation, and gene expression pathways linked to stress resistance and longevity.

Despite interest in anti-aging research communities, Epithalon is not approved for therapeutic use by the U.S. Food and Drug Administration or other major regulatory agencies. Most evidence supporting its potential benefits comes from in vitro studies, animal experiments, or limited small-scale human research rather than large, well-controlled clinical trials. Claims regarding lifespan extension or significant telomere lengthening in humans remain unproven in mainstream medical science. Products marketed as Epithalon are typically labeled for research use only and are not regulated to pharmaceutical manufacturing standards. Because safety, optimal dosing, and long-term effects in humans have not been firmly established, individuals should exercise caution and consult qualified healthcare professionals before considering experimental peptide compounds.